The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
NCT07315997
This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start preventative treatment earlier.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Rheumatoid Arthritis (RA
- Atherosclerotic Cardiovascular Disease (ASCVD)
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 35 to 79 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Brigham and Women's Hospital
- Last updated on ClinicalTrials.gov
- July 14, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 3
- Brigham and Women's Faulkner Hospital · Boston, MA
- Brigham and Womens Hospital · Boston, MA
- Massachusetts General Hospital: Rheumatology · Boston, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.